Lu AF28996

DRUG6 trials

Sponsors

H. Lundbeck A/S

Conditions

Healthy ParticipantsParkinson DiseaseParkinson's Disease

Phase 1

Lu AF28996 in Participants With Parkinson's Disease (PD)

CompletedNCT04291859

H. Lundbeck A/SParkinson Disease

Start: 2020-02-26End: 2026-02-12Updated: 2026-03-06

A Trial Investigating Lu AF28996 in Adult Japanese Participants With Parkinson's Disease (PD)

CompletedNCT06004180

H. Lundbeck A/SParkinson Disease

Start: 2023-09-12End: 2023-11-21Updated: 2023-12-11

A Trial Investigating Lu AF28996 in Healthy Adult Participants

CompletedNCT06277609

H. Lundbeck A/SHealthy Participants

Start: 2024-02-27End: 2024-05-19Updated: 2024-06-11

A Study Investigating the Movement of Lu AF28996 Into, Through, and Out of the Body of Healthy Men

CompletedNCT06337110

H. Lundbeck A/SHealthy Participants

Start: 2024-04-10End: 2024-05-11Updated: 2024-10-04

A Trial of Lu AF28996 in Participants With Parkinson's Disease (PD)

Not yet recruitingNCT07513441

H. Lundbeck A/SParkinson Disease

Start: 2026-03-31End: 2027-05-31Target: 10Updated: 2026-04-07

Phase 2

A Trial Investigating Lu AF28996 in Adults With Parkinson's Disease Who Have Motor Fluctuations

Not yet recruitingNCT07514858

H. Lundbeck A/SParkinson's Disease

Start: 2026-06-30End: 2028-12-30Target: 150Updated: 2026-04-07